 Jeniann Yi
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vascular Surgical Procedures | 8 | 2023 | 303 | 2.810 |
Why?
| | Endovascular Procedures | 9 | 2024 | 312 | 2.700 |
Why?
| | Blood Vessel Prosthesis Implantation | 5 | 2024 | 202 | 2.340 |
Why?
| | Operating Rooms | 3 | 2025 | 123 | 2.210 |
Why?
| | Electronic Health Records | 4 | 2025 | 1069 | 1.560 |
Why?
| | Aortic Aneurysm, Thoracic | 2 | 2023 | 131 | 1.390 |
Why?
| | Workflow | 3 | 2025 | 165 | 1.200 |
Why?
| | Kidney Failure, Chronic | 2 | 2023 | 570 | 1.000 |
Why?
| | Carotid Stenosis | 2 | 2024 | 91 | 1.000 |
Why?
| | Aortic Aneurysm, Abdominal | 2 | 2024 | 140 | 0.980 |
Why?
| | Meaningful Use | 1 | 2024 | 12 | 0.900 |
Why?
| | Peripheral Vascular Diseases | 2 | 2022 | 103 | 0.900 |
Why?
| | Incisional Hernia | 1 | 2024 | 3 | 0.890 |
Why?
| | Sexism | 2 | 2023 | 61 | 0.890 |
Why?
| | Efficiency, Organizational | 2 | 2025 | 140 | 0.880 |
Why?
| | Thrombosis | 3 | 2023 | 371 | 0.860 |
Why?
| | Pandemics | 4 | 2022 | 1639 | 0.810 |
Why?
| | Racism | 2 | 2023 | 135 | 0.790 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 93 | 0.770 |
Why?
| | Referral and Consultation | 2 | 2025 | 786 | 0.760 |
Why?
| | Congresses as Topic | 1 | 2023 | 233 | 0.750 |
Why?
| | Spinal Cord Ischemia | 1 | 2022 | 56 | 0.740 |
Why?
| | Surgeons | 3 | 2023 | 297 | 0.720 |
Why?
| | Renal Dialysis | 3 | 2023 | 435 | 0.720 |
Why?
| | Salaries and Fringe Benefits | 1 | 2021 | 56 | 0.710 |
Why?
| | Cost Savings | 1 | 2021 | 84 | 0.700 |
Why?
| | Medical Informatics | 1 | 2021 | 101 | 0.670 |
Why?
| | Personnel Selection | 1 | 2021 | 78 | 0.670 |
Why?
| | Physicians, Women | 1 | 2021 | 83 | 0.660 |
Why?
| | Treatment Outcome | 15 | 2025 | 10811 | 0.640 |
Why?
| | Stents | 5 | 2024 | 527 | 0.640 |
Why?
| | Fibrinolytic Agents | 1 | 2022 | 270 | 0.620 |
Why?
| | Administrative Claims, Healthcare | 1 | 2018 | 26 | 0.590 |
Why?
| | Hospital Charges | 1 | 2018 | 44 | 0.590 |
Why?
| | Stroke | 3 | 2024 | 1120 | 0.570 |
Why?
| | Peripheral Arterial Disease | 2 | 2022 | 475 | 0.570 |
Why?
| | Reimbursement Mechanisms | 1 | 2018 | 85 | 0.560 |
Why?
| | Quality Improvement | 3 | 2022 | 1178 | 0.540 |
Why?
| | Thoracic Outlet Syndrome | 1 | 2016 | 16 | 0.530 |
Why?
| | Ribs | 1 | 2016 | 35 | 0.520 |
Why?
| | Osteotomy | 2 | 2018 | 119 | 0.510 |
Why?
| | Incidental Findings | 1 | 2016 | 87 | 0.500 |
Why?
| | Vascular Malformations | 1 | 2016 | 52 | 0.500 |
Why?
| | Research Design | 1 | 2022 | 1139 | 0.490 |
Why?
| | Lymph | 1 | 2015 | 32 | 0.470 |
Why?
| | Health Care Costs | 1 | 2018 | 398 | 0.460 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 93 | 0.460 |
Why?
| | Humans | 37 | 2025 | 137585 | 0.450 |
Why?
| | Median Arcuate Ligament Syndrome | 2 | 2025 | 8 | 0.440 |
Why?
| | Time Factors | 6 | 2025 | 6828 | 0.420 |
Why?
| | Shock, Hemorrhagic | 1 | 2015 | 167 | 0.410 |
Why?
| | Risk Factors | 8 | 2024 | 10388 | 0.410 |
Why?
| | Retrospective Studies | 10 | 2025 | 15657 | 0.380 |
Why?
| | Adenocarcinoma | 2 | 2020 | 940 | 0.340 |
Why?
| | Celiac Artery | 2 | 2025 | 17 | 0.290 |
Why?
| | United States | 7 | 2024 | 14841 | 0.290 |
Why?
| | Risk Assessment | 4 | 2024 | 3457 | 0.270 |
Why?
| | Sex Factors | 2 | 2023 | 2071 | 0.260 |
Why?
| | Female | 15 | 2025 | 73304 | 0.250 |
Why?
| | Ovarian Neoplasms | 1 | 2012 | 565 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 2 | 2016 | 2691 | 0.250 |
Why?
| | Postoperative Hemorrhage | 2 | 2016 | 86 | 0.230 |
Why?
| | Male | 11 | 2025 | 67762 | 0.230 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 806 | 0.220 |
Why?
| | Lithotripsy | 1 | 2024 | 48 | 0.210 |
Why?
| | Robotic Surgical Procedures | 1 | 2025 | 130 | 0.210 |
Why?
| | Middle Aged | 9 | 2025 | 33479 | 0.200 |
Why?
| | Databases, Factual | 3 | 2018 | 1357 | 0.200 |
Why?
| | Mammography | 1 | 2024 | 154 | 0.200 |
Why?
| | Vascular Patency | 1 | 2023 | 106 | 0.200 |
Why?
| | Graft Occlusion, Vascular | 1 | 2023 | 40 | 0.200 |
Why?
| | Constriction, Pathologic | 1 | 2023 | 245 | 0.200 |
Why?
| | Enoxaparin | 1 | 2023 | 63 | 0.200 |
Why?
| | Iliac Aneurysm | 1 | 2022 | 19 | 0.200 |
Why?
| | Vascular Calcification | 1 | 2024 | 108 | 0.200 |
Why?
| | Patients | 1 | 2023 | 175 | 0.190 |
Why?
| | Arteries | 1 | 2023 | 269 | 0.180 |
Why?
| | Dyslipidemias | 1 | 2023 | 176 | 0.180 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 259 | 0.180 |
Why?
| | Root Cause Analysis | 1 | 2021 | 7 | 0.180 |
Why?
| | Human Rights | 1 | 2021 | 28 | 0.180 |
Why?
| | Aged, 80 and over | 3 | 2024 | 7635 | 0.180 |
Why?
| | Multicenter Studies as Topic | 1 | 2022 | 310 | 0.180 |
Why?
| | Specialties, Surgical | 1 | 2022 | 75 | 0.170 |
Why?
| | Burns, Electric | 1 | 2020 | 26 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2022 | 162 | 0.170 |
Why?
| | Cultural Diversity | 1 | 2021 | 77 | 0.170 |
Why?
| | Communication | 2 | 2023 | 879 | 0.170 |
Why?
| | Embolization, Therapeutic | 1 | 2022 | 229 | 0.170 |
Why?
| | Health Plan Implementation | 1 | 2021 | 142 | 0.170 |
Why?
| | Quality of Life | 2 | 2022 | 2892 | 0.160 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 67 | 0.160 |
Why?
| | Morbidity | 1 | 2021 | 324 | 0.160 |
Why?
| | Societies, Medical | 1 | 2023 | 820 | 0.160 |
Why?
| | Atherosclerosis | 1 | 2023 | 415 | 0.150 |
Why?
| | Foot | 1 | 2020 | 96 | 0.150 |
Why?
| | Tendons | 1 | 2020 | 111 | 0.150 |
Why?
| | Intermittent Claudication | 1 | 2020 | 118 | 0.150 |
Why?
| | Ischemia | 1 | 2022 | 409 | 0.150 |
Why?
| | General Surgery | 1 | 2021 | 173 | 0.150 |
Why?
| | Hyoid Bone | 1 | 2018 | 2 | 0.150 |
Why?
| | Aspirin | 1 | 2022 | 387 | 0.150 |
Why?
| | Arteriovenous Shunt, Surgical | 1 | 2018 | 18 | 0.150 |
Why?
| | Infection Control | 1 | 2020 | 167 | 0.150 |
Why?
| | Current Procedural Terminology | 1 | 2018 | 19 | 0.150 |
Why?
| | Nerve Compression Syndromes | 1 | 2018 | 21 | 0.150 |
Why?
| | Catheterization, Central Venous | 1 | 2020 | 112 | 0.150 |
Why?
| | Femoral Vein | 1 | 2018 | 34 | 0.150 |
Why?
| | Intracranial Embolism | 1 | 2018 | 32 | 0.150 |
Why?
| | Carotid Artery Injuries | 1 | 2018 | 41 | 0.150 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 273 | 0.150 |
Why?
| | Hematoma | 1 | 2018 | 53 | 0.150 |
Why?
| | Urban Health Services | 1 | 2018 | 63 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2021 | 512 | 0.150 |
Why?
| | Carotid Artery Diseases | 1 | 2018 | 64 | 0.140 |
Why?
| | Colonic Neoplasms | 1 | 2020 | 258 | 0.140 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2022 | 463 | 0.140 |
Why?
| | Vena Cava, Inferior | 1 | 2018 | 71 | 0.140 |
Why?
| | Laparoscopy | 1 | 2022 | 466 | 0.140 |
Why?
| | Muscle Weakness | 1 | 2018 | 88 | 0.140 |
Why?
| | Patient Reported Outcome Measures | 1 | 2021 | 402 | 0.140 |
Why?
| | Vena Cava Filters | 1 | 2018 | 61 | 0.140 |
Why?
| | Vascular System Injuries | 1 | 2018 | 71 | 0.140 |
Why?
| | Global Health | 1 | 2021 | 386 | 0.140 |
Why?
| | Running | 1 | 2020 | 230 | 0.140 |
Why?
| | Colorado | 2 | 2018 | 4565 | 0.140 |
Why?
| | Rural Health Services | 1 | 2018 | 128 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 261 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 664 | 0.130 |
Why?
| | Patient Readmission | 1 | 2023 | 697 | 0.130 |
Why?
| | Aged | 5 | 2024 | 23961 | 0.130 |
Why?
| | Program Evaluation | 1 | 2021 | 898 | 0.130 |
Why?
| | Venous Thrombosis | 1 | 2018 | 190 | 0.130 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 674 | 0.130 |
Why?
| | Blood Loss, Surgical | 1 | 2016 | 101 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1622 | 0.120 |
Why?
| | Alarmins | 1 | 2015 | 26 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 591 | 0.120 |
Why?
| | Mesentery | 1 | 2015 | 48 | 0.120 |
Why?
| | Bacterial Translocation | 1 | 2015 | 43 | 0.120 |
Why?
| | Electrical Equipment and Supplies | 1 | 2015 | 9 | 0.120 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 373 | 0.120 |
Why?
| | Coronavirus Infections | 1 | 2020 | 364 | 0.120 |
Why?
| | Adult | 6 | 2025 | 37929 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1040 | 0.110 |
Why?
| | Equipment Failure | 1 | 2015 | 108 | 0.110 |
Why?
| | Lower Extremity | 1 | 2018 | 427 | 0.110 |
Why?
| | Hypertension | 1 | 2023 | 1295 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2020 | 786 | 0.110 |
Why?
| | Postoperative Complications | 2 | 2025 | 2654 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2021 | 951 | 0.110 |
Why?
| | Intraoperative Complications | 1 | 2015 | 138 | 0.110 |
Why?
| | Practice Guidelines as Topic | 1 | 2021 | 1587 | 0.100 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 257 | 0.100 |
Why?
| | Telemedicine | 1 | 2022 | 862 | 0.100 |
Why?
| | Liver | 1 | 2020 | 1943 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2111 | 0.090 |
Why?
| | Internship and Residency | 1 | 2021 | 1147 | 0.090 |
Why?
| | Burns | 1 | 2015 | 325 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 1 | 2015 | 2486 | 0.080 |
Why?
| | Incidence | 1 | 2016 | 2804 | 0.080 |
Why?
| | Treatment Failure | 2 | 2022 | 356 | 0.080 |
Why?
| | Computed Tomography Angiography | 2 | 2018 | 129 | 0.070 |
Why?
| | Operative Time | 1 | 2025 | 145 | 0.060 |
Why?
| | Patient Portals | 1 | 2024 | 45 | 0.050 |
Why?
| | Patient Navigation | 1 | 2024 | 81 | 0.050 |
Why?
| | Ligaments | 1 | 2022 | 60 | 0.050 |
Why?
| | Heparin | 1 | 2023 | 261 | 0.050 |
Why?
| | Blood Coagulation | 1 | 2023 | 255 | 0.050 |
Why?
| | Abdominal Pain | 1 | 2022 | 145 | 0.040 |
Why?
| | Patient Participation | 1 | 2024 | 420 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2022 | 405 | 0.040 |
Why?
| | Arginase | 1 | 2020 | 32 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 956 | 0.040 |
Why?
| | Tenotomy | 1 | 2020 | 15 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2020 | 257 | 0.040 |
Why?
| | Tendon Transfer | 1 | 2020 | 23 | 0.040 |
Why?
| | Aorta | 1 | 2022 | 417 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 106 | 0.040 |
Why?
| | Macrophage Activation | 1 | 2020 | 201 | 0.040 |
Why?
| | Quality Indicators, Health Care | 1 | 2021 | 307 | 0.040 |
Why?
| | Ultrasonography, Doppler, Duplex | 1 | 2018 | 43 | 0.040 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 278 | 0.040 |
Why?
| | Retroperitoneal Space | 1 | 2018 | 20 | 0.040 |
Why?
| | Phlebography | 1 | 2018 | 38 | 0.040 |
Why?
| | Head Movements | 1 | 2018 | 19 | 0.040 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2018 | 39 | 0.040 |
Why?
| | Physical Endurance | 1 | 2020 | 275 | 0.040 |
Why?
| | Cerebral Angiography | 1 | 2018 | 109 | 0.040 |
Why?
| | Health Care Surveys | 1 | 2020 | 565 | 0.040 |
Why?
| | Patient Positioning | 1 | 2018 | 67 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2020 | 545 | 0.030 |
Why?
| | Blood Vessel Prosthesis | 1 | 2018 | 127 | 0.030 |
Why?
| | Cryopreservation | 1 | 2018 | 100 | 0.030 |
Why?
| | Animals | 2 | 2020 | 36940 | 0.030 |
Why?
| | Device Removal | 1 | 2018 | 136 | 0.030 |
Why?
| | Betacoronavirus | 1 | 2020 | 270 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 660 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 153 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2020 | 364 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2020 | 810 | 0.030 |
Why?
| | Education, Medical, Graduate | 1 | 2021 | 486 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2022 | 1477 | 0.030 |
Why?
| | Qualitative Research | 1 | 2023 | 1386 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2024 | 2828 | 0.030 |
Why?
| | Reoperation | 1 | 2018 | 573 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 653 | 0.030 |
Why?
| | Palliative Care | 1 | 2022 | 758 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1060 | 0.030 |
Why?
| | United States Food and Drug Administration | 1 | 2015 | 208 | 0.030 |
Why?
| | Fires | 1 | 2015 | 89 | 0.030 |
Why?
| | Adolescent | 2 | 2025 | 21513 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2021 | 1171 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2021 | 1329 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2757 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2020 | 3412 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2020 | 4295 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2020 | 5757 | 0.020 |
Why?
| | Infant | 1 | 2023 | 9465 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5472 | 0.020 |
Why?
| | Young Adult | 1 | 2025 | 13209 | 0.020 |
Why?
| | Signal Transduction | 1 | 2020 | 5079 | 0.020 |
Why?
| | Child | 1 | 2023 | 21935 | 0.010 |
Why?
| | Mice | 1 | 2020 | 17787 | 0.010 |
Why?
|
|
Yi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|